MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis - Test2 - elhamkhani - TriplyDB

MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis

MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis

http://www.wikidata.org/entity/Q35111108

about

Noncoding RNAs in DNA repair and genome integrity Multistep model of cervical cancer: participation of miRNAs and coding genes Deregulated miRNAs in human cervical cancer: functional importance and potential clinical use.miR-372 down-regulates the oncogene ATAD2 to influence hepatocellular carcinoma proliferation and metastasis.A Comprehensive Review of Dysregulated miRNAs Involved in Cervical Cancer.MicroRNAs, genomic instability and cancer.MicroRNA expression signatures determine prognosis and survival in glioblastoma multiforme--a systematic overview.Low mir-372 expression correlates with poor prognosis and tumor metastasis in hepatocellular carcinoma Upregulation of miR-372 and -373 associates with lymph node metastasis and poor prognosis of oral carcinomas.miR-372 inhibits p62 in head and neck squamous cell carcinoma in vitro and in vivo.Epigallocatechin-3-Gallate Upregulates miR-221 to Inhibit Osteopontin-Dependent Hepatic Fibrosis.Regulatory mechanisms and clinical perspectives of miRNA in tumor radiosensitivity.miR-346 Up-regulates Argonaute 2 (AGO2) Protein Expression to Augment the Activity of Other MicroRNAs (miRNAs) and Contributes to Cervical Cancer Cell Malignancy Correlation of microRNA-372 upregulation with poor prognosis in human glioma.CUL4B promotes replication licensing by up-regulating the CDK2-CDC6 cascade.MicroRNA-372 inhibits endometrial carcinoma development by targeting the expression of the Ras homolog gene family member C (RhoC).Nip the HPV encoded evil in the cancer bud: HPV reshapes TRAILs and signaling landscapes Serum microRNA expression levels can predict lymph node metastasis in patients with early-stage cervical squamous cell carcinoma Smoking and microRNA dysregulation: a cancerous combination.Increased exosomal microRNA-21 and microRNA-146a levels in the cervicovaginal lavage specimens of patients with cervical cancer.MicroRNAs and DNA damage response: implications for cancer therapy.Epigenetics and cervical cancer: from pathogenesis to therapy.MicroRNAs in cervical cancer: evidences for a miRNA profile deregulated by HPV and its impact on radio-resistance.Epigenetic Alterations in Human Papillomavirus-Associated Cancers.Association of tumour microRNA profiling with outcomes in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy.miR-372 suppresses tumour proliferation and invasion by targeting IGF2BP1 in renal cell carcinoma.miR-372 regulates glioma cell proliferation and invasion by directly targeting PHLPP2.Upregulation of microRNA-372 associates with tumor progression and prognosis in hepatocellular carcinoma.MicroRNAs in gynecological cancers: Small molecules with big implications.MiR-520b as a novel molecular target for suppressing stemness phenotype of head-neck cancer by inhibiting CD44.MiRNA expression signature for potentially predicting the prognosis of ovarian serous carcinoma.Pre-microRNA Gene Polymorphisms and Risk of Cervical Squamous Cell Carcinoma.microRNAs and Acute Myeloid Leukemia Chemoresistance: A Mechanistic Overview.miR-372 promotes breast cancer cell proliferation by directly targeting LATS2.Meta-analysis of microRNA expression profiling studies in human cervical cancer.Identification of a microRNA signature associated with survivability in cervical squamous cell carcinoma.Identification of key pathways and genes in the progression of cervical cancer using bioinformatics analysis.

P2860

Q26864697-F346F828-8066-4D53-B7BE-AE929C0F9CA8 Q27001000-0565D744-514C-4FCC-9E46-66856BAD6042 Q30241934-B3AB71F1-BCEA-49FF-942C-B9A13D0205BB Q33592473-F4E4E0D6-1C5D-4FF0-B8BB-C1D69DC595E3 Q34049716-1CBF24B5-BDE7-40AA-86AC-E5765186F835 Q34158633-B33DB84C-A8F4-484F-9CA5-38E3D4F8F524 Q34409620-ECD3EDEF-C4B6-4901-A409-6A736E2CD03D Q35233796-B693BC79-0686-4CEA-928D-9936EEE19761 Q35685531-C046A842-EC06-416C-B667-9F357E3B0280 Q35742465-F655A0BD-03B0-4810-BC69-FAB5F86DE165 Q36217669-35F9AD32-548B-4085-AF5B-8B5F2C6C1E7A Q36353046-0E5B86FF-9553-4BEF-A6E5-41644BA9DAF6 Q36381912-F2F88EAC-5967-4A98-B020-F87C5F63E9C2 Q36552246-9901A8B7-CBE8-490B-B70D-FF96DA944B3F Q36695607-D38C8596-1C67-4389-9294-53633DB13339 Q36916304-23E54837-68DD-401E-92EB-05C6B19251A8 Q36952911-BCF642FC-BAB9-4CDE-997A-886A71D4CF0E Q37196131-24C3A36E-E549-434D-A1FB-F4DD82D5CC4D Q37432727-13CC0DB3-10D9-4415-BF02-4AE3692C9A47 Q37535528-185ABD9D-06E3-4558-A363-D7B8F48AEE79 Q38068797-F821B385-0340-47C1-9899-A94062033491 Q38189740-D0FFECBA-D67A-4C43-A948-A8279D5F3D67 Q38212798-79524919-0820-47BF-B8E1-570EA5A4B615 Q38598051-31528769-0918-4F31-8C19-2E7029EA41AE Q38761348-A78DDC7A-36A1-45B7-8C04-CA5AEA4B4E98 Q38838597-183BAD30-D24F-420D-8844-0FBD63AFE99B Q38962553-AD8C26FE-6EA4-4782-933D-06651246B7B0 Q39215878-98CE8EDD-9396-44E9-A086-B0F0D5DAAB51 Q39333266-5AE1F7D5-0BCE-43B3-A06C-6FA60B661414 Q42259492-0722C3E9-744E-48BC-BE17-614379BA3B00 Q45942073-C55A376F-796D-45DE-AF61-3704571D774C Q47162734-98EF4148-F982-46D4-8BAD-4001576C2ABC Q47375547-93416863-A2F4-4503-94C5-54AB8F8DC7E0 Q49875543-6FEEB711-B3D0-40E6-9511-71EB9F47FC1F Q50983395-A6D04A68-6294-45B8-9842-58F7C6142D0B Q52669413-E312A226-92B3-4EED-BDE5-85288D6A1487 Q55347847-118A7BF3-BCD9-4659-BE37-537775CB014F

P2860

MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis

http://www.wikidata.org/entity/Q35111108

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

MicroRNA-372 is down-regulated ...... ay contribute to tumorigenesis

@ast

MicroRNA-372 is down-regulated ...... ay contribute to tumorigenesis

@en

type

label

MicroRNA-372 is down-regulated ...... ay contribute to tumorigenesis

@ast

MicroRNA-372 is down-regulated ...... ay contribute to tumorigenesis

@en

prefLabel

MicroRNA-372 is down-regulated ...... ay contribute to tumorigenesis

@ast

MicroRNA-372 is down-regulated ...... ay contribute to tumorigenesis

@en

P1433

Q35111108-2123E869-B69D-44F4-AEF9-3DEF7BF54F81

P1476

Q35111108-0A3CCEE0-4BB3-4C37-9351-DF78701E0F0B

P2093

Q35111108-0910D923-BBD6-4ADE-8535-56FD463F0156

Q35111108-6CC66053-EF91-4AE8-97B2-39323AFABDF2

Q35111108-7CCBF588-24FA-4912-9142-F727600CAD2A

Q35111108-9C69B577-15B9-4606-9579-6F5A2B7C4C20

Q35111108-C440D4EB-E86B-44BC-8C17-5A0E10ED0582

Q35111108-CAAF6C4C-4D3A-42BF-9B09-DE7FAD16A7CC

Q35111108-D124B7AA-D6A3-4AF1-9E48-322A73E4D53C

Q35111108-D1BC398A-DE4B-438F-80E2-46EF1F95D7E7

Q35111108-D63BB04B-84E1-41BF-A68B-1E816B1BF269

P2860

Q35111108-01C1118A-BEC2-4061-82ED-FBCEA1810B8F

Q35111108-0ECD92D1-5CEF-48F6-91B5-8B38A20B2546

Q35111108-0FECF6AD-6B2A-4E68-AF4B-78A53F93884D

Q35111108-27140C0D-5711-46DC-B18C-67D8E85C6AE4

Q35111108-296E9CEE-0090-472C-9D2D-DB639E571F9D

Q35111108-31C4EED4-A2F4-4718-A258-AF188FC2B274

Q35111108-32E35100-2644-48E9-B64E-B14AA2ABA63E

Q35111108-36BCB135-D7F7-4C50-869C-63D14031F47E

Q35111108-377D26A6-B24F-4C92-B02D-53E28A17EC67

Q35111108-37943811-0C0B-4783-AB6E-191E987ACB50

P304

Q35111108-07AC391F-B6DF-42CE-A943-B3055D6B0CB5

P31

Q35111108-9E295E50-1A6A-4C01-9178-AD5B0E558C92

P356

Q35111108-9F000EFF-A201-4C93-B3F1-9C44EA3A1BF0

P407

Q35111108-66D4BD6F-97A2-4E5E-AB3D-69E5A9B03886

P433

Q35111108-54592F38-4B6F-451A-A40A-F118EAA32924

P478

Q35111108-48B47E69-C62F-468F-9AF9-D15390972DB3

P577

Q35111108-F82AF5BC-A220-4645-9B85-B7175B0147C1

P5875

Q35111108-376BF201-8B36-45DA-8D51-F0A200CAA818

P698

Q35111108-A38531E8-4400-4499-8257-FE96EE1954A1

P921

Q35111108-173637B1-7CE3-4BBF-894E-C353AC76696D

P932

Q35111108-2D956887-5F6D-4321-B487-D0B2D102D0A1

P356

JBC.M111.221564

P1433

Journal of Biological Chemistry

P1476

MicroRNA-372 is down-regulated ...... ay contribute to tumorigenesis

@en

P2093

Hua Tang

http://www.w3.org/2001/XMLSchema#string

Li-Juan Hou

http://www.w3.org/2001/XMLSchema#string

Min Liu

http://www.w3.org/2001/XMLSchema#string

Qian Yang

http://www.w3.org/2001/XMLSchema#string

Rui-Qing Tian

http://www.w3.org/2001/XMLSchema#string

Wei-Hua Jia

http://www.w3.org/2001/XMLSchema#string

Xin Li

http://www.w3.org/2001/XMLSchema#string

Xing-Hua Wang

http://www.w3.org/2001/XMLSchema#string

Yi-Xuan Li

http://www.w3.org/2001/XMLSchema#string

P2860

The Hallmarks of Cancer

Characterization of a second human cyclin A that is highly expressed in testis and in several leukemic cell lines

Functions of cyclin A1 in the cell cycle and its interactions with transcription factor E2F-1 and the Rb family of proteins

Accumulation of miR-155 and BIC RNA in human B cell lymphomas

The Six1 homeoprotein stimulates tumorigenesis by reactivation of cyclin A1

CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer

MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1

RAS is regulated by the let-7 microRNA family

An extensive class of small RNAs in Caenorhabditis elegans

MicroRNA gene expression deregulation in human breast cancer

P304

25556-25563

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M111.221564

http://www.w3.org/2001/XMLSchema#string

P407

P433

29

http://www.w3.org/2001/XMLSchema#string

P478

286

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51196528

http://www.w3.org/2001/XMLSchema#string

P698

21646351

http://www.w3.org/2001/XMLSchema#string

P921

P932

3138314

http://www.w3.org/2001/XMLSchema#string